Skip to main content
. 2015 Sep-Oct;21(5):295–299. doi: 10.4103/1319-3767.164189

Figure 1.

Figure 1

Proportion of patients overall achieving a complete virological response (CVR), partial virological response (PVR), or no response to TDF after 48 weeks of treatment